Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | -9.58% | -28.33% | -5.83% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
Financials (USD)
Sales 2024 * | 68.34M | Sales 2025 * | 84.72M | Capitalization | 650M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -108M | EV / Sales 2024 * | 9.51 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.67 x |
P/E ratio 2024 * |
-4.82
x | P/E ratio 2025 * |
-4.88
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.32% |
Latest transcript on Ocular Therapeutix, Inc.
1 day | -9.58% | ||
1 week | -28.33% | ||
Current month | -53.85% | ||
1 month | -55.37% | ||
3 months | -2.10% | ||
6 months | +78.72% | ||
Current year | -5.83% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 17-09-24 |
Chief Tech/Sci/R&D Officer | - | 21-09-27 | |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 23-07-09 |
Director/Board Member | 76 | 12-11-04 | |
Merilee Raines
BRD | Director/Board Member | 68 | 21-09-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +5.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.2 | -9.58% | 4,699,359 |
24-04-24 | 4.645 | -7.10% | 3,954,779 |
24-04-23 | 5 | -1.48% | 2,278,666 |
24-04-22 | 5.075 | -2.78% | 3,745,815 |
24-04-19 | 5.22 | -10.92% | 9,125,811 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.83% | 719M | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- OCUL Stock